JPRN-UMIN000004678已完成未知
Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetes - Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetes
Keio University , School of Mecidicine, Department of Internal Medicine0 个研究点目标入组 50 人开始时间: 2011年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Type 1 diabetes mellitus 2.Impaired renal function [serum-creatinine; =>1.5mg/dL(male), =>1.3mg/dL(female) or eGFR<30mL/min] 3.Severe liver dysfunction [AST, ALT=>3 fold above ULN] 4.Patients who are disqualified from the study by investigator for any reasons.
研究者
相似试验
已完成
不适用
A Study of Safety and Efficacy of DPP-4 inhibitor in the Treatment of type 2 diabetes in KanagawaType 2 diabetesJPRN-UMIN000014382Diabetes Committee, Kanagawa Physicians Association860
已完成
不适用
The efficacy and the safety of the DPP4 inhibitor in patients with type 2 diabetes complicated with renal dysfunctiodiabetes mellitusJPRN-UMIN000030172Osaka Saiseikai Noe Hospital400
已完成
不适用
Examination of the usefulness of DPP-4 inhibitor in the treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000011862aka Kinen Clinic10
已完成
不适用
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney diseaseJPRN-UMIN000018464ihon University School of Medicine100
招募中
不适用
Efficacy and safety of DPP-4 inhibitors in patients with chronic kidney diseaseChronic kidney diseaseJPRN-UMIN000009493ihon University School of Medicine30